Please see below for full reference list
Abidoye, O. et al., 2025. Upper-Extremity Deep Venous Thrombosis after Whole Blood Donation—A Case Report. International Journal of Angiology, 34(2), pp. 111-114. doi: 10.1055/s-0042-1756216.
Adkins, B. D., Sharma, D. & Eichbaum, Q., 2020. Can we better predict delayed hemolytic transfusion reactions and hyperhemolysis in sickle cell disease? Transfusion and Apheresis Science, 59(2), p. 102681. doi: https://doi.org/10.1016/j.transci.2019.102681.
Alwakeal, A. et al., 2024. Fixed- Versus Variable-Dose Prothrombin Complex Concentrate for the Emergent Reversal of Vitamin K Antagonists: A Systematic Review and Meta-Analysis. Critical Care Medicine, 52(5), pp. 811-820. doi: https://doi.org/10.1097/ccm.0000000000006212.
Association for the Advancements of Blood & Biotherapis (AABB), 2026. Switzerland to Remove Donor Deferrals Related to vCJD Risk. [Online] Available at: https://www.aabb.org/news-resources/news/article/2026/01/14/switzerland-to-remove-donor-deferrals-related-to-vcjd-risk [Accessed 17 April 2026].
Austin, E. et al., 2009. Guidelines for the Estimation of Fetomaternal Haemorrhage. British Committee for Standards in Haematology (BCSH), pp. 1-23. Available at: https://b-s-h.org.uk/guidelines/guidelines/bsh-guideline-for-the-estimation-of-fetomaternal-haemorrhage [Accessed 24 February 2026].
Birkeli, G., Deilkås, E. C. T., Ballangrud, R. & Lindahl, A. K., 2025. Implementing Learning from Excellence in a postanaesthesia care unit: a qualitative study of healthcare professionals’ experiences after six months. BMC Health Services Research, Volume 25. doi: https://doi.org/10.12968/bjhc.2023.0119.
British Association of Perinatal Medicine (BAPM), 2025. Safety Alert: Lookalike IV administration giving sets. [Online] Available at: https://www.bapm.org/articles/safety-alert-lookalike-iv-administration-giving-sets [Accessed 20 February 2026].
Buka, R. J. et al., 2025. A UK-wide analysis of 2265 patients receiving a reversal agent for direct oral anticoagulant–associated bleeding. Journal of Thrombosis and Haemostasis, 24(3), pp. 900-912. doi: https://doi.org/10.1016/j.jtha.2025.11.003.
Carson, J. L. et al., 2023. Restrictive or Liberal Transfusion Strategy in Myocardial Infarction and Anemia. The New England Journal of Medicine, 389(26), pp. 2446-2456. doi:10.1056/NEJMoa2307983.
Catchpole, K. & Russ, S., 2015. The problem with checklists. BMJ Quality & Safety, 24(9), pp. 545-549. doi: https://doi.org/10.1136/bmjqs-2015-004431.
Chance, E. A., Florence, D. & Abdoul, I. S., 2024. The effectiveness of checklists and error reporting systems in enhancing patient safety and reducing medical errors in hospital settings: A narrative review. International Journal of Nursing Sciences, 11(3), pp. 387-398. doi: https://doi.org/10.1016/j.ijnss.2024.06.003.
Covin, R. B., Rich, N. L. & Aysola, A., 2004. Upper-extremity deep venous thrombosis complicating whole-blood donation. Transfusion, 44(4), pp. 586-590. doi: https://doi.org/10.1111/j.1537-2995.2004.03278.x.
Crossingham, G. et al., 2023. Learning from excellence: a thematic analysis of staff-reported excellence in healthcare from two acute NHS trusts. British Journal of Healthcare Management, 29(11). doi: https://doi.org/10.12968/bjhc.2023.0024.
Danaee, A., Inusa, B., Howard, J. & Robinson, S., 2015. Hyperhemolysis in Patients With Hemoglobinopathies: A Single-Center Experience and Review of the Literature. Transfusion Medicine Reviews, 29(4), pp. 220-230. doi: https://doi.org/10.1016/j.tmrv.2015.06.001.
Davis, B. A. et al., 2017. Guidelines on red cell transfusion in sickle cell disease. Part I: principles and laboratory aspects. British Journal of Haematology, 176(2), pp. 179-191. doi: https://doi.org/10.1111/bjh.14346.
Department of Health, 2005. The Blood Safety and Quality Regulations 2005. [Online] Available at: https://www.legislation.gov.uk/uksi/2005/50/introduction/made [Accessed 19 February 2026].
Department of Health & Social Care, 2025. Independent report Executive summary: hepatitis E virus transmission by blood transfusion – review of current screening effectiveness. [Online] Available at: https://www.gov.uk/government/publications/sabto-hepatitis-e-virus-hev-screening-review-and-recommendations/executive-summary-hepatitis-e-virus-transmission-by-blood-transfusion-review-of-current-screening-effectiveness [Accessed 17 April 2026].
Department of Health and Social Care, 2013. Measures currently in place in the UK to reduce the potential risk of vCJD transmission via blood. [Online] Available at: https://www.gov.uk/government/news/measures-currently-in-place-in-the-uk-to-reduce-the-potential-risk-of-vcjd-transmission-via-blood [Accessed 17 April 2026].
Department of Health and Social Care, 2023. Guidance: Occult hepatitis B infection in UK blood donors. [Online] Available at: https://www.gov.uk/government/publications/occult-hepatitis-b-infection-in-uk-blood-donors [Accessed 17 April 2026].
Department of Health and Social Care, 2026. Policy paper Renewed Women’s Health Strategy for England. [Online] Available at: https://www.gov.uk/government/publications/renewed-womens-health-strategy-for-england [Accessed 17 April 2026].
Estcourt, L. J. et al., 2017. Guidelines for the use of platelet transfusions. British Journal of Haematology, 176(3), pp. 365-394. doi: https://doi.org/10.1111/bjh.14423.
European Committee on Blood Transfusion (Partial Agreement) (CD-P-TS), 2025. Guide to the preparation, use and quality assurance of Blood Components. 22nd ed. s.l.:European Directorate for the Quality of Medicines and Healthcare (EDQM). [Online] Available at: https://www.edqm.eu/en/blood-guide.
Featherstone, T. & Bayliss, A. P., 1987. Deep venous thrombosis of the upper extremity – a case report. Angiology, 38(10), pp. 793-796. doi: https://doi.org/10.1177/000331978703801010.
Gawande, A., 2011. The Checklist Manisfesto. s.l.:Picador Paper.
Gilstad, C. W., Conry-Cantilena, K., Zarpak, R. & Eder, A. F., 2023. An outbreak of anaphylactic transfusion reactions to group B plasma and platelets and its possible relationship to Alpha-Gal syndrome. Transfusion, 63(10), pp. 1997-2000. doi: https://doi.org/10.1111/trf.17521.
Goldman, M., Land, K., Robillard, P. & Wiersum-Osselton, J., 2016. Development of standard definitions for surveillance of complications related to blood donation. Vox Sanguinis, Feb, 110(2), pp. 185-8. doi: https://doi.org/10.1111/vox.12323.
Hackett, K. et al., 2015. A concept mapping study evaluating the UK’s first NHS generic fatigue clinic. Health Expectations, 19(5), pp. 1138-1149.
Harvala, H., Reynolds, C., Brailsford, S. & Davison, K., 2022. Fulminant Transfusion-Associated Hepatitis E Virus Infection Despite Screening, England, 2016-2020. Emerging Infectious Diseases, 28(9), pp. 1805-1813. doi: https://doi.org/10.3201/eid2809.220487.
Health & Care Professions Council (HCPC), 2024. The duty of candour. [Online] Available at: https://www.hcpc-uk.org/standards/meeting-our-standards/raising-concerns-openness-and-honesty/the-duty-of-candour/ [Accessed 17 March 2026].
Health Services Safety Investigations Body (HSSIB), 2025a. Patient safety issues associated with electronic patient record (EPR) systems – a thematic review. [Online] Available at: https://www.hssib.org.uk/patient-safety-investigations/electronic-patient-record-epr-systems-thematic-review/investigation-report/ [Accessed 17 April 2026].
Health Services Safety Investigations Body (HSSIB), 2025b. Investigation report: The impact of staff fatigue on patient safety. [Online] Available at: https://www.hssib.org.uk/patient-safety-investigations/the-impact-of-staff-fatigue-on-patient-safety/investigation-report/ [Accessed 29 January 2026].
Hoad, V. C. et al., 2023. Removal of UK-donor deferral for variant Creutzfeldt–Jakob disease: A large donation gain in Australia. Vox Sanguinis, 118(10), pp. 891-894. doi: https://doi.org/10.1111/vox.13510.
Homssi, A. A. et al., 2025. Fixed-Dose Four-Factor Prothrombin Complex Concentrate for Reversal of Anticoagulation: Evaluation of Efficacy, Safety, and Cost Savings. Journal of hematology, 14(4), pp. 234-239. doi: https://doi.org/10.14740/jh2078.
Iacobucci, G., 2026. Corridor care: Patients collapsing in overcrowded spaces, NHS watchdog warns. BMJ, 08 January. [Online] Available at: https://doi.org/10.1136/bmj.s41.
Infected Blood Inquiry (IBI), 2024. The Report HC 569-I, London: Crown. Available at: https://www.infectedbloodinquiry. org.uk/reports/inquiry-report [Accessed 25 March 2026].
Joint United Kingdom (UK) Blood Transfusion and Tissue Transplantation Services Professional Advisory Committee (JPAC), 2022. Allergy. [Online] Available at: https://www.jpac.org.uk/guidelines/wb/index/allergy/ [Accessed 07 May 2026].
Joint United Kingdom Blood Transfusion and Tissue Transplantation Services Professional Advisory Committee (JPAC), 2024a. Position Statements. The estimated residual risk that a donation made in the infectious window period is not detected on testing: Risks specific for HBV, HCV and HIV in the UK (2021–2023). [Online] Available at: https://www.jpac.org.uk/resources-and-documents/position-statements/ [Accessed 07 May 2026].
Joint United Kingdom Blood Transfusion and Tissue Transplantation Services Professional Advisory Committee (JPAC), 2024b. Position Statements. Variant Creutzfeldt-Jakob disease (vCJD). [Online] Available at: https://www.jpac.org.uk/resources-and-documents/position-statements/ [Accessed 07 May 2026].
Joint United Kingdom Blood Transfusion and Tissue Transplantation Services Professional Advisory Committee (JPAC), 2026. Position Statements. Surveillance: Preparedness for emerging infectious agents. [Online] Available at: https://www.jpac.org.uk/resources-and-documents/position-statements/ [Accessed 07 May 2026].
Kahraman, S. et al., 2005. Painful traumatic neuroma after a finger stick. Anesthesia & Analgesia, 100(5), pp. 1414-1415. doi: https://doi.org/10.1213/01.ane.0000149547.88277.43.
Kumar, M. M. et al., 2024. Intraoperative cell salvage: a survey of UK practice. British Journal of Anaesthesia, 132(5), pp. 995-997. doi: https://doi.org/10.1016/j.arth.2008.06.019.
Lee, W. Q., Li, Y. & Yeo, N. E. M., 2023. Glomus tumour: an institutional experience of 31 cases. Journal of Orthopaedic Surgery and Research, 18(741). doi: https://doi.org/10.1186/s13018-023-04234-1.
Lucas, G. et al., 2012. Reducing the incidence of TRALI in the UK: the results of screening for donor leucocyte antibodies and the development of national guidelines. Vox Sanguinis, 103(1), pp. 10-17. doi: https://doi.org/10.1111/j.1423-0410.2011.01570.x.
Mackie, F. L. et al., 2017. The accuracy of cell-free fetal DNA-based non-invasive prenatal testing in singleton pregnancies: a systematic review and bivariate meta-analysis. An International Journal of Obstretrics and Gynaecology, 124(1), pp. 32-46. doi: https://doi.org/10.1111/1471-0528.14050.
Malone, C. et al., 2024. Exploring the effects of learning from excellence: a qualitative study of staff perspectives. British Journal of Healthcare Management, 30(2). doi: https://doi.org/10.12968/bjhc.2022.0120.
Maternity & Newborn Safety Investigations (MNSI), 2025. Safety Spotlight: Exchange blood transfusion. [Online] Available at: https://www.mnsi.org.uk/publications/safety-spotlight-exchange-blood-transfusion/ [Accessed 20 February 2026].
Matsumoto, M. et al., 2022. Association of Staphylococcus aureus in platelet concentrates with skin diseases in blood donors: Limitations of cultural bacterial screening. Transfusion, 62(3), pp. 621-632. doi: https://doi.org/10.1111/trf.16804.
McDonald, C. et al., 2017. Bacterial screening of platelet components by National Health Service Blood and Transplant, an effective risk reduction measure. Transfusion, 57(5), pp. 1122-1131. doi: https://doi.org/10.1111/trf.14085.
Medicines & Healthcare products Regulatory Agency (MHRA) and Serious Hazards of Transfusion (SHOT), 2024. Central Alerting System: Reducing risks for transfusion-associated circulatory overload. [Online] Available at: https://www.cas.mhra.gov.uk/ViewandAcknowledgment/ViewAlert.aspx?AlertID=103249 [Accessed 10 February 2026].
Medicines and Healthcare products Regulatory Agency (MHRA), 2010. Guidance Electronic issue of blood components. [Online] Available at: https://www.gov.uk/government/publications/electronic-issue-of-blood-component [Accessed 16 April 2026].
Medicines and Healthcare products Regulatory Agency (MHRA), 2023. Collection: Blood regulation and safety. [Online] Available at: https://www.gov.uk/government/collections/blood-regulation-and-safety.
Medicines and Healthcare products Regulatory Agency (MHRA), 2024. National Patient Safety Alert: Reducing risks for transfusion-associated circulatory overload (NatPSA/2024/004/MHRA). [Online] Available at: https://www.gov.uk/drug-device-alerts/national-patient-safety-alert-reducing-risks-for-transfusion-associated-circulatory-overload-natpsa-slash-2024-slash-004-slash-mhra [Accessed 24 March 2026].
Medicines and Healthcare products Regulatory Agency (MHRA), n.d. Forum: Blood Forum. [Online] Available at: https://forums.mhra.gov.uk/forumdisplay.php?60-Blood-Forum.
Mehta, P. & Dubrey, S., 2009. High output heart failure. QJM: An International Journal of Medicine, 102(4), pp. 235-241. doi: https://doi.org/10.1093/qjmed/hcn147.
Milkins, C. et al., 2013. Guidelines for pre-transfusion compatibility procedures in blood transfusion laboratories. Transfusion Medicine, 23(1), pp. 3-35. doi: https://doi.org/10.1111/j.1365-3148.2012.01199.x.
Mirrione-Savin, A. et al., 2025. Frequencies and causes of ABO-incompatible red cell transfusions in France, Germany and the United Kingdom. British Journal of Haematology, 206(2), pp. 726-734. doi: https://doi.org/10.1111/bjh.19848.
Montgomery, A. et al., 2025. Psychological safety and patient safety: A systematic and narrative review. PLoS One, 20(4), p. e0322215. doi: https://doi.org/10.1371/journal.pone.0322215.
Moon, A., 2017. Blog: MHRA Inspectorate. [Online] Available at: https://mhrainspectorate.blog.gov.uk/2017/02/06/overview-of-compliance-management-escalation-processes-used-by-the-gmp-inspectorate/ [Accessed 15 May 2026].
Murphy, M. F. et al., 2025. Guidelines from the expert advisory committee on the Safety of Blood, Tissues and Organs (SaBTO) on patient consent and shared decision-making for blood transfusion. British Journal of Haematology, 207(6), pp. 2314-2321. doi: https://doi.org/10.1111/bjh.70075.
Murphy, M. F. & Toh, C. H., 2026. Transforming transfusion practice in the National Health Service to enhance safety, efficiency and clinical outcomes. British Journal of Haematology, 208(2), pp. 459-470. doi: https://doi.org/10.1111/bjh.70321.
Narayan, S. et al., 2022. The 2021 Annual SHOT Report, Manchester: Serious Hazards of Transfusion (SHOT) Steering Group. doi: https://doi.org/10.57911/qzf9-xe84.
Narayan, S. et al., 2024. The 2023 Annual SHOT Report, Manchester: Serious Hazards of Transfusion (SHOT) Steering Group. doi: https://doi.org/10.57911/605r-em59.
Narayan, S. et al., 2025. The 2024 Annual SHOT Report, Manchester: Serious Hazards of Transfusion (SHOT) Steering Group. doi: https://doi.org/10.57911/gwcz-4q04.
National Blood Service Blood and Transplant (NHSBT); National Blood Transfusion (NBTC); UK Thalassaemia Society (UKTS); UK Sickle Cell Society (SCS), 2024. Guidelines on red cell transfusion in sickle cell disease. Part I: principles and laboratory aspects. (British Journal of Haematology 2016; 176; 179-191). Addendum January 2024. [Online] Available at: https://b-s-h.org.uk/guidelines/guidelines/guidelines-on-red-cell-transfusion-in-sickle-cell-disease-part-i-principles-and-laboratory-aspects [Accessed 27 March 2026].
National Blood Transfusion Committee (NBTC), 2024. Indication Codes for Transfusion in Adults – A Summary of published recommendations 2024 Update, England: National Blood Transfusion Committee. Available at: https://www.nationalbloodtransfusion.co.uk/sites/default/files/documents/2024-10/NBTC-indication-codes-V3-2024.pdf [Accessed 26 January 2026].
National Blood Transfusion Committee (NBTC), 2025a. Documents and Resources for National Transfusion Practitioners Network. [Online] Available at: https://nationalbloodtransfusion.co.uk/sites/default/files/news/2025-12/NTPN-survey-findings-v3.pdf [Accessed 15 April 2026].
National Blood Transfusion Committee (NBTC), 2025b. Survey of Hospital Transfusion Committees 2025. [Online] Available at: https://nbtc-up.targeted.agency/audits-and-surveys/survey-hospital-transfusion-committees-2025 [Accessed 17 April 2026].
National Comparative Audit of Blood Transfusion (NCABT), 2025. 2024 National Comparative Audit of NICE Quality Standard QS138, England: NHS Blood and Transplant. [Online] Available at: https://hospital.blood.co.uk/audits/national-comparative-audit/reports-grouped-by-year/2025-audit-of-nice-quality-standard-qs138/.
National Health Service Blood and Transplant (NHSBT), 2025a. Clinical issue of apheresis platelets in platelet additive solution (PAS) and plasma. [Online] Available at: https://hospital.blood.co.uk/the-update/clinical-issue-of-apheresis-platelets-in-platelet-additive-solution-pas-and-plasma/ [Accessed 04 April 2026].
National Health Service Blood and Transplant (NHSBT), 2025b. Patient information leaflets. [Online] Available at: https://hospital.blood.co.uk/patient-services/patient-blood-management/patient-information-leaflets/ [Accessed 27 March 2026].
National Health Service Blood and Transplant (NHSBT), 2026. 2026 National Comparative Audit of the use of prophylactic anti-D in pregnancy. [Online] Available at: https://hospital.blood.co.uk/audits/national-comparative-audit/reports-grouped-by-year/2026-national-comparative-audit-on-the-use-of-prophylactic-anti-d-in-pregnancy/ [Accessed 23 January 2026].
National Health Service Blood and Transplant and UK Health Security Agency Epidemiology Unit (NHSBT and UKHSA), 2025. Epidemiology Unit: annual review. [Online] Available at: https://hospital.blood.co.uk/diagnostic-services/microbiology-services/epidemiology/annual-review/ [Accessed 17 April 2026].
National Health Service England (NHSE), 2015. Serious Incident framework. [Online] Available at: https://www.england.nhs.uk/wp-content/uploads/2020/08/serious-incidnt-framwrk.pdf [Accessed 19 February 2026].
National Health Service England (NHSE), 2020a. Rituximab and eculizumab for the prevention and management of delayed haemolytic transfusion reactions and hyperhaemolysis in patients with haemoglobinopathies. [Online] Available at: https://www.england.nhs.uk/publication/rituximab-and-eculizumab-for-the-prevention-and-management-of-delayed-haemolytic-transfusion-reactions-and-hyperhaemolysis-in-patients-with-haemoglobinopathies/ [Accessed 25 January 2026].
National Health Service England (NHSE), 2020b. Clinical Commissioning Policy; Rituximab and eculizumab for the prevention and management of delayed haemolytic transfusion reactions and hyperhaemolysis in patients with haemoglobinopathies [URN 1821] [200602P], England: National Health Service England.
National Health Service England (NHSE), 2023. DCB0160: Clinical Risk Management: its Application in the Deployment and Use of Health IT Systems. [Online] Available at: https://digital.nhs.uk/data-and-information/information-standards/governance/latest-activity/standards-and-collections/dcb0160-clinical-risk-management-its-application-in-the-deployment-and-use-of-health-it-systems/ [Accessed 21 April 2026].
National Health Service England (NHSE), 2025a. Digital clinical safety assurance. [Online] Available at: https://www.england.nhs.uk/long-read/digital-clinical-safety-assurance/ [Accessed 21 April 2026].
National Health Service England (NHSE), 2025b. Interoperability Toolkit. [Online] Available at: https://digital.nhs.uk/services/interoperability-toolkit [Accessed 16 April 2026].
National Health Service England (NHSE), 2026. Part of Digital Maturity Assessment report 2024 and 2025 results: Key Findings. [Online] Available at: https://digital.nhs.uk/data-and-information/digital-maturity-assessment-report-2024-and-2025-results/key-findings [Accessed 21 April 2026].
National Institute for Health and Care Excellence (NICE), 2016. High-throughput non-invasive prenatal testing for fetal RHD genotype. [Online] Available at: https://www.nice.org.uk/guidance/dg25 [Accessed 20 January 2025].
National Institute for Health and Clinical Excellence (NICE), 2020. Anaphylaxis: assessment and referral after emergency treatment. [Online] Available at: https://www.nice.org.uk/guidance/cg134 [Accessed 24 April 2026].
New, H. V. et al., 2016. Guidelines on transfusion for fetuses, neonates and older children. British Journal of Haematology, 175(5), pp. 784-828. doi: https://doi.org/10.1111/bjh.14233.
Ngan, C. B. M., Kaur, R. & Jackson, D. E., 2024. Does high body mass index (>25 kg/m 2) or weight (>80 kg) reduce the effectiveness of anti-D prophylaxis in Rh(D)-negative pregnant women? A systematic review and meta-analysis. Vox Sanguinis, 119(9), pp. 902-911. doi: https://doi.org/10.1111/vox.13693.
Plunkett, A. & Plunkett, E., 2022. Positive approaches to safety: Learning from what we do well. Paediatric Anaesthesia, 32(11), pp. 1223-1229. doi: https://doi.org/10.1111/pan.14509.
Qureshi, H. et al., 2014. BCSH guideline for the use of anti-D immunoglobulin for the prevention of haemolytic disease of the fetus and newborn. Transfusion Medicine, 24(1), pp. 1-66. doi: https://doi.org/10.1111/tme.12091.
Reijngoud, L. W. et al., 2009. Does Intraoperative Cell Salvage Remove Cobalt and Chromium from Reinfused Blood? The Journal of Arthroplasty, 24(7), pp. 1125-1129. doi: https://doi.org/10.1016/j.arth.2008.06.019.
Robinson, S. et al., 2018. The administration of blood components: a British Society for Haematology Guideline. Transfusion Medicine, 28(1), pp. 3-21. doi: https://doi.org/10.1111/tme.12481.
Royal College of Emergency Medicine (RCEM), 2025. ‘A national shame’: Research reveals devastating reality of so called ‘corridor care’. [Online] Available at: https://rcem.ac.uk/press-release/a-national-shame-research-reveals-devastating-reality-of-so-called-corridor-care/ [Accessed 29 January 2026].
Royal College of Physicians (RCP), 2025. Doctors confirm ‘corridor care’ crisis as 80% forced to treat patients in unsafe spaces. [Online] Available at: https://www.rcp.ac.uk/news-and-media/news-and-opinion/doctors-confirm-corridor-care-crisis-as-80-forced-to-treat-patients-in-unsafe-spaces/ [Accessed 29 January 2026].
Saba, M. et al., 2021. Rare glomus tumor formation following trauma to the first digit. International journal of surgery case reports, 86(C), p. 106324. doi: https://doi.org/10.1016/j.ijscr.2021.106324.
Samaniego, E., Crespo, A. & Sanz, A., 2009. Key Diagnostic Features and Treatment of Subungual Glomus Tumor. Actas Dermo-Sifiliográficas, 100(10), pp. 875-882. doi: https://doi.org/10.1016/S1578-2190(09)70558-X.
Schrader, E., Zinser, B., Kulhari, A. & Craven, C., 2026. Evaluating the use of fixed versus variable dosing of 4-factor prothrombin complex concentrate in anticoagulant-related major bleeding. The American journal of emergency medicine, Volume 99, pp. 276-279. doi: https://doi.org/10.1016/j.ajem.2025.10.019.
Şener, K. et al., 2025. A rare complication of blood donation: MINOCA. The American Journal of Emergency Medicine, Volume 88, pp. 274.e1-274.e3. doi: https://doi.org/10.1016/j.ajem.2024.12.003.
Serious Hazards of Transfusion (SHOT), 2022. Central Alerting System: Preventing transfusion delays in bleeding and critically anaemic. [Online] Available at: https://www.cas.mhra.gov.uk/ViewandAcknowledgment/ViewAlert.aspx?AlertID=103190 [Accessed 25 March 2026].
Serious Hazards of Transfusion (SHOT), 2025a. UKTLC Surveys. [Online] Available at: https://www.shotuk.org/resources/uktlc-surveys/ [Accessed 23 April 2026].
Serious Hazards of Transfusion (SHOT), 2025b. https://www.shotuk.org/transfusion-safety/transfusion-safety-standards/safety-standards/. [Online] Available at: https://www.shotuk.org/transfusion-safety/transfusion-safety-standards/safety-standards/ [Accessed 20 April 2026].
Simons, D., 2010. selective attention test. s.l.:Daniel J. Simons. [Online] Available at: https://www.youtube.com/watch?v=vJG698U2Mvo.
Sollof, J., 2024. DHI Snapshot Report examines Trust Digital Maturity Assessment scores. digitalhealth, 18 April. [Online] Available at: https://www.digitalhealth.net/2024/04/dhi-snapshot-report-examines-trust-digital-maturity-assessment-scores/. [Accessed 21 April 2026].
Soutar, R. et al., 2023. Guideline on the investigation and management of acute transfusion reactions. British Journal of Haematology, 201(5), pp. 832-844. doi: https://doi.org/10.1111/bjh.18789.
Swarbrick, N., Poles, D., Tuckley, V. & Narayan, S., 2024. ABO incompatible red cell transfusion events and near misses in the United Kingdom; prevention is better than cure. Barcelona, International Society of Blood Transfusion (ISBT). doi: https://doi.org/10.1111/vox.13652.
Tognola, C. et al., 2025. Myocardial Infarction with Nonobstructive Coronary Arteries (MINOCA): Current Insights into Pathophysiology, Diagnosis, and Management. Diagnostics, 15(7), p. 942. doi: https://doi.org/10.3390/diagnostics15070942.
Townsend, M. et al., 2020. Development and validation of donor adverse reaction severity grading tool: enhancing objective grade assignment to donor adverse events. Transfusion, 60(6), pp. 1231-1242. doi: https://doi.org/10.1111/trf.15830.
U.S. Food & Drug Administration (FDA), 2022. Recommendations to Reduce the Possible Risk of Transmission of Creutzfeldt-Jakob Disease and Variant Creutzfeldt-Jakob Disease by Blood and Blood Components. [Online] Available at: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/recommendations-reduce-possible-risk-transmission-creutzfeldt-jakob-disease-and-variant-creutzfeldt [Accessed 17 April 2026].
UK Cell Salvage Action Group (UKCSAG), n.d. Competency Workbooks. [Online] Available at: https://www.jpac.org.uk/transfusion-practice/uk-cell-salvage-action-group/competency/ [Accessed 07 May 2026].
UK Health Security Agency, 2025. Guidance Alpha-gal Syndrome. [Online] Available at: https://www.gov.uk/guidance/alpha-gal-syndrome [Accessed 04 April 2026].
Uncu, H. et al., 2024. Efficacy of human prothrombin complex concentrate in the treatment of warfarin overdose in patients receiving warfarin for mechanical heart valve replacement. Medicine (Baltimore), 103(19), p. e38022. doi: https://doi.org/10.1097/md.0000000000038022.
Vickers, M., Murphy, M., Graham, R. & Neuberger, J., 2025. We should implement electronic blood management systems across the UK to improve blood transfusion safety. BMJ, Volume 389, p. r700. doi: https://doi.org/10.1136/bmj.r700.
Vlaar, A. P. et al., 2019. A consensus redefinition of transfusion-related acute lung injury. Transfusion, 59(7), pp. 2465-2476. doi: https://doi.org/10.1111/trf.15311.
Welsh Government, 2025. Infected blood inquiry: implementing recommendation 7e, SHOT reports (WHC/2025/037). [Online] Available at: https://www.gov.wales/infected-blood-inquiry-implementing-recommendation-7e-shot-reports-whc2025037-html [Accessed 21 April 2026].
West, M., Eckert, R., Steward, K. & Pasmore, B., 2014. Developing collective leadership for health care, North Carolina: The King’s Fund. [Online] Available at: https://assets.kingsfund.org.uk/f/256914/x/9406fe95d0/developing_collective_leadership_2014.pdf [Accessed 21 April 2026].
Wiersum-Osselton, J. C. et al., 2019. Revised international surveillance case definition of transfusion-associated circulatory overload: a classification agreement validation study. The Lancet, 6(7), pp. E350-E358. doi: https://doi.org/10.1016/S2352-3026(19)30080-8.
Williamson, L. M., Heptonstall, J. & Soldan, K., 1996. A SHOT in the arm for safer blood transfusion. BMJ, 313(7067), p. 1221. doi: https://doi.org/10.1136/bmj.313.7067.1221.
Wise, J., 2025. Electronic patient records pose “persistent” risk to patient safety, watchdog warns. BMJ, 391(r2519). doi: https://doi.org/10.1136/bmj.r2519.
World Health Organization (WHO), 2009. Safe surgery: Tool and Resources – WHO Surgical Safety Checklist. [Online] Available at: https://www.who.int/teams/integrated-health-services/patient-safety/research/safe-surgery/tool-and-resources [Accessed 05 May 2026].
Zapata, A. O. et al., 2021. Central retinal artery occlusion as a post-transfusion complication of red blood cells. Archivos de la Sociedad Española de Oftalmología, 96(5), pp. 265-269. doi: https://doi.org/10.1016/j.oftal.2020.06.013.